NOV 22, 2017 01:59 PM PST

Bi-Specific Antibodies- New Improvements to Cancer Immunotherapy

In the last several years, immunotherapy has been hailed as the therapeutic breakthrough for cancer that we’ve all been waiting for.  The ability to utilize and manipulate our own immune systems to eradicate cancer is not only highly promising, but has already proven effective in a subset of patients in the clinic – and this is not just in one cancer type – but many.  A lot of attention has been given to immune checkpoint blockade in highly mutagenic cancers such as melanoma and those of the lung, as well as to chimeric antigen receptor T-cell therapy (CAR-T therapy), but a third category is now gaining more attention as well.  This category is that of bispecific antibodies, or BsAbs.   Interestingly, bispecific antibodies were originally hypothesized to be a method to combat cancer as early as the 1980s.  These work through their affinity to two different targets which act to promote tumor progression.  By binding these targets, they in essence block their ability to interact with their normal partners and are then unable exert their oncogenic effects.  They also have the ability to link therapeutic agents to cancer cells to deliver the desired blow of the therapies.  This video, published by Roche in May of 2016, details the use of T-cell bispecific antibodies for use in cancer.

Sources: Roche, Youtube, Nature Reviews

 

 

 

 

About the Author
You May Also Like
SEP 16, 2019
Drug Discovery
SEP 16, 2019
Antidepressants May Impair Empathy
Depression is tagged with strong impairments of social functioning. Until recently, researchers believed that acute depression impairs empathy—a nece...
SEP 16, 2019
Drug Discovery
SEP 16, 2019
Experimental Drug Encourages Bone Growth in Children with Dwarfism
An experimental drug called vosoritide, alters certain proteins that block bone growth, which allowed the average annual growth of bone in a study of 35 ch...
SEP 16, 2019
Cell & Molecular Biology
SEP 16, 2019
Scratching a Chronic Itch
There are many potential reasons why skin might itch, but this annoying condition can significantly impact quality of life when it doesn't go away....
SEP 16, 2019
Drug Discovery
SEP 16, 2019
Promising Drug Encourages Survival in Pancreatic Cancer
Building on almost 20 years of research, a phase 1 clinical trial drug for pancreatic cancer, named ‘AZD1775’, shows promising initial results ...
SEP 16, 2019
Cardiology
SEP 16, 2019
Somethings Fishy With Omega 3 Claims
Each month nearly 20 million Americans turn to fish oil for heart disease prevention. Though it may sound healthy, this trend is troubling in the face of z...
SEP 16, 2019
Drug Discovery
SEP 16, 2019
Does Adderall Really Work for People without ADHD?
Adderall is a popular stimulant. Known to treat Attention Deficit Disorder (ADHD), those without the condition also use it to increase attention, focus and...
Loading Comments...